- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
What has COVID-19 Taught the US About Flu?
Vaccination against flu is the best protection from the infection according to 61% of US adults surveyed by NFID. How do the rest feel about the threat?
The best preventive measure against influenza is to get the flu shot agree 61% of US adults surveyed by the National Foundation for Infectious Diseases (NFID); 44% of survey respondents, however, say they are either unsure of whether they will get the shot or do not plan to be vaccinated against influenza during the 2021-2022 flu season.
The reasons for not taking the vaccine include the belief that the vaccines don't work very well, that they have concerning side effects, and some US adults are sure that they "never get the flu."
Our slide-show summary of the NFID survey results highlights more attitudes, beliefs, and potential behaviors around the flu and its treatment as well as how COVID-19 has affected the way US adults perceive the threat of flu infection.
